<DOC>
	<DOC>NCT02808572</DOC>
	<brief_summary>To evaluate the relationships between bone mineral metabolism markers (osteoprotegerin, fibroblast growth factor 23) at inclusion and the occurence of cardiovascular events during a 3 year follow-up.</brief_summary>
	<brief_title>New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Patient who has signed the written consent form Patient with chronic renal failure defined by glomerular filtration rate (GFR) but without dialysis therapy Pregnancy Patient with chronic renal failure requiring dialysis therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>vascular calcifications</keyword>
	<keyword>cardiovascular risk</keyword>
</DOC>